Bausch Health Cos., Inc. (BHC.TO)
9.31
+0.08
(+0.87%)
CAD |
TSX |
Aug 25, 16:00
Bausch Health Cos. Shareholders Equity (Quarterly) : -2.513B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.513B |
| March 31, 2026 | -2.873B |
| December 31, 2025 | -759.40M |
| September 30, 2025 | -786.14M |
| June 30, 2025 | -1.042B |
| March 31, 2025 | -1.703B |
| December 31, 2024 | -1.839B |
| September 30, 2024 | -1.586B |
| June 30, 2024 | -1.608B |
| March 31, 2024 | -1.509B |
| December 31, 2023 | -1.348B |
| September 30, 2023 | -1.595B |
| June 30, 2023 | -877.31M |
| March 31, 2023 | -1.083B |
| December 31, 2022 | -937.63M |
| September 30, 2022 | -721.38M |
| June 30, 2022 | -893.94M |
| March 31, 2022 | -269.79M |
| December 31, 2021 | -133.89M |
| September 30, 2021 | -258.44M |
| June 30, 2021 | -850.71M |
| March 31, 2021 | -247.60M |
| December 31, 2020 | 681.59M |
| September 30, 2020 | 784.09M |
| June 30, 2020 | 645.59M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.023B |
| December 31, 2019 | 1.378B |
| September 30, 2019 | 3.286B |
| June 30, 2019 | 3.399B |
| March 31, 2019 | 3.598B |
| December 31, 2018 | 3.733B |
| September 30, 2018 | 4.076B |
| June 30, 2018 | 4.561B |
| March 31, 2018 | 5.704B |
| December 31, 2017 | 7.329B |
| September 30, 2017 | 6.662B |
| June 30, 2017 | 5.105B |
| March 31, 2017 | 5.192B |
| December 31, 2016 | 4.227B |
| September 30, 2016 | 5.477B |
| June 30, 2016 | 6.878B |
| March 31, 2016 | 7.315B |
| December 31, 2015 | 8.211B |
| September 30, 2015 | 8.503B |
| June 30, 2015 | 8.034B |
| March 31, 2015 | 8.172B |
| December 31, 2014 | 6.115B |
| September 30, 2014 | 5.725B |
| June 30, 2014 | 5.601B |
| March 31, 2014 | 5.618B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | 78.37M |
| Cipher Pharmaceuticals, Inc. | 194.73M |
| BioSyent, Inc. | 45.84M |
| Revive Therapeutics Ltd. | -4.025M |
| Knight Therapeutics, Inc. | 798.59M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 35.18B |
| Total Liabilities (Quarterly) | 36.31B |
| Debt to Equity Ratio | -11.73 |
| Current Ratio | 1.435 |
| Net Debt Paydown Yield | 11.31% |